J C Raeder, J van der Linden, H Breivik
Index: Acta Anaesthesiol. Scand. 30(7) , 502-6, (1986)
Full Text: HTML
A double-blind comparison of the effect of Ketogan (ketobemidone and A-29, an anticholinergic and spasmolytic agent) and morphine + scopolamine as premedication was performed in 113 women admitted for abortion and in 114 women admitted for gynaecological dilatation and curettage. Anaesthesia was thiopentone and nitrous oxide and oxygen, occasionally supplemented with enflurane. It was found that 1 ml morphine + scopolamine (10 mg + 0.4 mg) was more sedative than 1 ml ketogan (ketobemidone 5 mg + A-29 25 mg). After ketogan there was less nausea and dryness of the mouth before induction of anaesthesia than after morphine + scopolamine. Ketogan had the same tranquillizing effect but less hypnotic effect preoperatively than morphine + scopolamine. During the 3-h postoperative observation period the patients premedicated with ketogan woke up significantly sooner and had more pain than those given morphine + scopolamine. More patients required postoperative antiemetics in the ketogan-premedicated group than in the morphine + scopolamine-premedicated group.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
2-(3,3-diphenylpropyl)-1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazine
CAS:55011-89-7 |
C23H30N2 |
Clinical pharmacokinetics of ketobemidone. Its bioavailabili...
1981-02-01 [Eur. J. Clin. Pharmacol. 19(3) , 217-23, (1981)] |
The mu1 and mu2 opioid receptor binding of ketobemidone, nor...
1996-08-01 [Pharmacol. Toxicol. 79(2) , 103-4, (1996)] |
Ketobemidone plus (RS)-3-dimethylamino-1,1-diphenylbut-1-ene...
1998-03-01 [Pharmacol. Toxicol. 82(3) , 157-60, (1998)] |
Analgesic effect and bioavailability of oral ketogan given a...
1988-01-01 [Acta Oncol. 27(5) , 583-9, (1988)] |
Histamine release from human basophils and isolated rat mast...
1982-01-01 [Acta Pharmacol. Toxicol. (Copenh.) 50(1) , 78-80, (1982)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved